CRMD
Cormedix Inc
NASDAQ · Pharmaceuticals
$7.69
+0.34 (+4.63%)
Open$7.48
Previous Close$7.35
Day High$7.72
Day Low$7.40
52W High$17.43
52W Low$5.60
Volume—
Avg Volume2.33M
Market Cap605.89M
P/E Ratio3.73
EPS$2.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+582.7% upside
Current
$7.69
$7.69
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 58.18M | 151.82M | 142.81M |
| Net Income | -23,999,143 | 25.07M | 23.58M |
| Profit Margin | -41.2% | 16.5% | 16.5% |
| EBITDA | -29,018,005 | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +511.6% | +9.9% | -6.7% |
| Debt/Equity | — | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |